Schedule 13D ownership disclosure
RECURSION PHARMACEUTICALS INC CL A
Security class unavailable · CUSIP: 75629V104
Event date: 2021-04-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,740,917
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-21-004924
- Form type
- SC 13D
- Filer
- Mubadala Investment Co PJSC
- CIK
- CIK 1704268
- Filed
- Apr 26, 2021
- Reporting period
- Apr 16, 2021
- Description
- Schedule 13D beneficial ownership